Limitations of paired comparisons of topical drugs.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D001365:Axilla / Q000382:microbiology; D001419:Bacteria / Q000187:drug effects; D002224:Carbanilides / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004917:Erythromycin / Q000494:pharmacology; D006582:Hexachlorophene / Q000494:pharmacology*; D006801:Humans; D009355:Neomycin / Q000008:administration & dosage / Q000627:therapeutic use; D009779:Occlusive Dressings; D009824:Ointments; D010400:Penicillin G / Q000008:administration & dosage / Q000494:pharmacology; D010403:Penicillin Resistance; D010919:Placebos; D011725:Pyridines / Q000494:pharmacology*; D012867:Skin / Q000382:microbiology; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D012915:Soaps / Q000494:pharmacology; D013210:Staphylococcus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D002224:Carbanilides; D009824:Ointments; D010919:Placebos; D011725:Pyridines; D012915:Soaps; D004917:Erythromycin; D002701:Chloramphenicol; D009355:Neomycin; D006582:Hexachlorophene; D010400:Penicillin G